Lana Medical Company (TADAWUL: 9587)

Lana Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Dec 31, 2022	Dec 31, 2022	Dec 31, 2021
Revenue	40.8	40.8	31.97
Revenue Growth (YoY)	-	27.64%	-
Cost of Revenue	21.58	21.58	14.52
Gross Profit	19.22	19.22	17.45
Selling, General & Admin	11.17	11.17	9.05
Operating Expenses	12.7	12.7	10.13
Operating Income	6.52	6.52	7.32
Interest Expense	-0.2	-0.2	-0.08
Other Non Operating Income (Expenses)	0.29	0.29	0.54
EBT Excluding Unusual Items	6.62	6.62	7.78
Gain (Loss) on Sale of Assets	-	-	0.01
Pretax Income	6.62	6.62	7.79
Income Tax Expense	1.13	1.13	1.2
Net Income	5.49	5.49	6.59
Net Income to Common	5.49	5.49	6.59
Net Income Growth	-	-16.70%	-
Shares Outstanding (Basic)	3	3	2
Shares Outstanding (Diluted)	3	3	2
Shares Change (YoY)	-	37.11%	-
EPS (Basic)	1.83	1.83	3.01
EPS (Diluted)	1.83	1.83	3.01
EPS Growth	-	-39.25%	-
Free Cash Flow	0.36	0.36	-12.17
Free Cash Flow Per Share	0.12	0.12	-5.56
Gross Margin	47.11%	47.11%	54.58%
Operating Margin	15.99%	15.99%	22.90%
Profit Margin	13.46%	13.46%	20.63%
Free Cash Flow Margin	0.87%	0.87%	-38.06%
EBITDA	7.54	7.54	8.09
EBITDA Margin	18.47%	18.47%	25.30%
D&A For EBITDA	1.01	1.01	0.77
EBIT	6.52	6.52	7.32
EBIT Margin	15.99%	15.99%	22.90%
Effective Tax Rate	17.03%	17.03%	15.36%
Advertising Expenses	0.19	0.19	-

Source: S&P Capital IQ. Standard template. Financial Sources.